Clinical trials · Ohio
Non-Alcoholic Fatty Liver Disease clinical trials in Ohio
We’re tracking 6 recruiting non-alcoholic fatty liver disease studies with a site in Ohio — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in Ohio
- NCT06374875RecruitingPhase 4
Does metabolic surgery reduce liver scarring?
This study tests if weight loss surgery can improve liver fibrosis (scarring) in people with obesity and advanced liver disease. It may help those considering surgery to know if their liver health can get better.
Cleveland, OhioAges 18–75 - NCT07221188RecruitingPhase 3
Efimosfermin alfa for liver scarring in MASH
This study tests an investigational drug called efimosfermin alfa to see if it is safe and tolerable for people who have liver scarring (F2 or F3 stage) from a condition called MASH. The goal is to find out if the drug can help without causing serious side effects.
Akron, OhioAges 18–75 - NCT07221227RecruitingPhase 3
Testing a new drug for MASH with moderate scarring
This trial tests a new medicine called Efimosfermin Alfa for people with MASH (a fatty liver disease) and moderate liver scarring. It aims to see if the medicine can improve the liver condition.
Akron, OhioAges 18–75 - NCT06133101RecruitingPhase 2
Can soymilk help kids with fatty liver disease?
This study tests if drinking soymilk can improve liver health in children with non-alcoholic fatty liver disease (NAFLD). It may offer a simple dietary change to help manage the condition.
Cincinnati, OhioAges 5–12 - NCT06477146RecruitingPhase 2
Milk thistle for fatty liver in children and young adults
This trial tests whether milk thistle can help children and young adults with non-alcoholic fatty liver disease (NAFLD), a condition where fat builds up in the liver unrelated to alcohol use. It aims to see if the supplement can lower liver enzymes and improve liver health.
Cleveland, OhioAges 9–22 - NCT06632444RecruitingPhase 3
Study of survodutide for liver disease NASH/MASH with fibrosis
This trial tests an investigational drug called survodutide for people with NASH or MASH, a type of fatty liver disease that also has liver scarring (moderate or advanced fibrosis). The goal is to see if the drug can improve the condition.
Columbus, OhioAges 18 years+
Non-Alcoholic Fatty Liver Disease trials by city in Ohio
Where these studies are running in Ohio
Institutions with a site for the recruiting non-alcoholic fatty liver disease studies listed above.
- GSK Investigational Site · 2 studies
- Cincinnati Children's Hospital Medical Center
- Cleveland Clinic
- DSI Research, LLC
- Great Lakes Gastroenterology Research, LLC
- North Shore Gastroenterology Research
- The Ohio State University Wexner Medical Center
- University Hospitals Cleveland Medical Center
What taking part in a non-alcoholic fatty liver disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Non-Alcoholic Fatty Liver Disease trials in other states
Common questions
- Are there non-alcoholic fatty liver disease clinical trials in Ohio?
- Yes. We're currently tracking 6 recruiting non-alcoholic fatty liver disease studies with a site in Ohio, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a non-alcoholic fatty liver disease study in Ohio?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Ohio to take part?
- Not necessarily. These studies have a site in Ohio, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a non-alcoholic fatty liver disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New non-alcoholic fatty liver disease studies open in Ohio regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.